Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-10-26-Speech-3-294-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-10-26"^^xsd:date2
dcterms:Is Part Of	lp_eu:Public health threat of antimicrobial resistance (debate)2
dcterms:Language	"el"^^xsd:language2
lpv:document identification number	"en.20111026.20.3-294-000"2
lpv:hasSubsequent	lp_eu:2011-10-26-Speech-3-295-0002
lpv:speaker	lp:Theodoros Skylakakis2
lpv:spokenAs	substitute; CONT (2011-09-29--2012-01-18)3 member; Delegation for relations with the People's Republic of China (2009-09-16--2014-06-30)3 substitute; ECON (2011-06-22--2012-01-18)3 member_of_the_bureau; ALDE (2011-06-01--2014-06-30)3 unknown; Democratic Alliance (2011-06-14--2012-09-10)3 member; ENVI (2009-07-16--2012-01-18)3
lpv:translated text	"Mr President, no one expected a tsunami to hit Fukushima. Hardly anyone foresaw the economic crisis in 2008. Our societies are not well-prepared for outlier events. This applies above all to antibiotic-resistant microorganisms, given that, in the Darwinian sense, the development of a superbug resistant to modern antibiotics was only a matter of time. Antimicrobial resistance is a problem which clearly has cross-border dimensions. That is why the Treaty of Lisbon makes provision for the European Union to have competence and an obligation to act in this sector. Our defence in this instance is as strong as its weakest link. We must therefore focus on the countries with high levels of antimicrobial resistance and address the question of excessive use with interventions along the entire chain of citizens, doctors, chemists and the pharmaceutical industry. This will have very important economic and financial implications, because antibiotics are expensive. That is why Parliament’s vote in favour of a special action – which I proposed – within the framework of the 2012 budget, to extend research into the social and economic causes of indiscriminate use and to help plan an action programme in the most vulnerable countries, is a positive move. We must also acknowledge that there has been market failure, especially in terms of research and development of new antibiotics. As antibiotics are the last line of defence and must be used very economically, there is quite logically no incentive to develop them. That is why we must step up the debate and find such incentives. Finally, the key to the endeavour is to limit the widespread use of so-called broad spectrum antibiotics. It is absurd to use weapons of mass destruction where we can use smart bombs. That is why we are calling for more investment here. To close, we need to understand that, in practical terms, antimicrobial resistance wastes global resources that are non-renewable. That is why the Commission needs to table proposals and move ahead with the Council recommendation of November 2001 and ensure that it is applied more effectively."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph